Maria Szatkowski has lost a product bag at the last Friday night meeting. It has some product in it that she has to inventory. If you got the bag by accident could you please phone her at (269)598-8563.

Ivax (now owned by Teva Pharmaceuticals) have received FDA approval to market their generic version of AstraZeneca’s Pulmicort Respules in 0.25mg/ml and 0.5mg/ml strengths. More details here.

PITTSBURGH, Nov. 17 /PRNewswire-FirstCall/ — Mylan Inc. (NYSE: MYL) today announced that its subsidiary, Mylan Pharmaceuticals Inc., received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl) Extended-release (ER) Capsules, 37.5 mg (base), 75 mg (base) and 150 mg (base).
Venlafaxine HCl ER Capsules, […]

Osteoporosis Therapy UpdatesFormulary UpdatesTrivia & Prizes!
Friday, November 21, 2008
6:30PM Refreshments
7:00PM Hors d’oeuvres and Party
Limited to the first 30 reservations due to limited seating.If you are attending Thursday’s dinner, please consider others who might instead be able to attend tonight.
RSVP to William Urfer (269)381-2256 or william@swmpa.org by November 17.
Or use Google Calendar

CEU Pending.
Food Dance Cafe
401 E […]

The U.S. Food and Drug Administration has approved a new drug to help patients suffering from overactive bladder (OAB). Toviaz (fesoterodine fumarate) works by relaxing the smooth muscle tissue of the bladder, thus reducing the urinary frequency, urge to urinate, and sudden urinary incontinence (leakage of urine), that are characteristic symptoms […]